Name
ntprobnp__pg_ml
Label
N-terminal pro B-type natriuretic peptide
Units
picograms per milliliter
Type
numeric
Visit number vs N-terminal pro B-type natriuretic peptide
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 317 | 202.8 | ± 339.8 | 91.9 | 5.0 | 2,654.0 | 1 | 318 |
Follow-up | 298 | 215.7 | ± 437.6 | 84.7 | 5.0 | 4,369.0 | 3 | 301 |
Treatment Arm vs N-terminal pro B-type natriuretic peptide
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 317 | 202.8 | ± 339.8 | 91.9 | 5.0 | 2,654.0 | 1 | 318 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 106 | 206.1 | ± 330.6 | 100.3 | 5.0 | 2,565.0 | - | 106 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 105 | 207.0 | ± 382.7 | 79.3 | 5.8 | 2,654.0 | 1 | 106 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 106 | 195.3 | ± 305.0 | 93.8 | 5.0 | 1,856.0 | - | 106 |
Treatment Arm vs N-terminal pro B-type natriuretic peptide
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 298 | 215.7 | ± 437.6 | 84.7 | 5.0 | 4,369.0 | 3 | 301 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 100 | 279.0 | ± 595.4 | 101.3 | 7.6 | 4,369.0 | - | 100 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 100 | 183.9 | ± 353.7 | 85.1 | 7.7 | 2,760.0 | 1 | 101 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 98 | 183.6 | ± 301.0 | 73.5 | 5.0 | 1,881.0 | 2 | 100 |
Age category vs N-terminal pro B-type natriuretic peptide
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 317 | 202.8 | ± 339.8 | 91.9 | 5.0 | 2,654.0 | 1 | 318 |
45-54 years | 53 | 108.1 | ± 192.0 | 43.9 | 5.0 | 1,121.0 | - | 53 |
55-64 years | 139 | 203.6 | ± 368.5 | 90.9 | 6.3 | 2,654.0 | - | 139 |
65 years or older | 125 | 242.2 | ± 349.6 | 119.0 | 14.4 | 2,565.0 | 1 | 126 |
Age category vs N-terminal pro B-type natriuretic peptide
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 298 | 215.7 | ± 437.6 | 84.7 | 5.0 | 4,369.0 | 2 | 300 |
45-54 years | 48 | 102.3 | ± 117.0 | 50.5 | 5.0 | 489.1 | 1 | 49 |
55-64 years | 126 | 217.6 | ± 481.2 | 80.2 | 5.0 | 4,369.0 | 1 | 127 |
65 years or older | 124 | 257.6 | ± 463.7 | 121.5 | 7.6 | 3,185.0 | - | 124 |
Gender of the participant vs N-terminal pro B-type natriuretic peptide
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 317 | 202.8 | ± 339.8 | 91.9 | 5.0 | 2,654.0 | 1 | 318 |
Female | 83 | 156.8 | ± 281.5 | 80.5 | 5.0 | 2,260.0 | 1 | 84 |
Male | 234 | 219.1 | ± 357.3 | 97.1 | 5.0 | 2,654.0 | - | 234 |
Gender of the participant vs N-terminal pro B-type natriuretic peptide
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 298 | 215.7 | ± 437.6 | 84.7 | 5.0 | 4,369.0 | 3 | 301 |
Female | 78 | 159.5 | ± 342.4 | 71.3 | 8.7 | 2,760.0 | 1 | 79 |
Male | 220 | 235.6 | ± 465.8 | 93.5 | 5.0 | 4,369.0 | 2 | 222 |
Race of the participant vs N-terminal pro B-type natriuretic peptide
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 201.9 | ± 340.0 | 91.7 | 5.0 | 2,654.0 | 1 | 317 |
White | 256 | 211.0 | ± 343.4 | 96.3 | 5.0 | 2,654.0 | - | 256 |
American Indian or Alaskan Native | 2 | 35.3 | ± 3.3 | 35.3 | 32.9 | 37.7 | - | 2 |
Black or African American | 42 | 186.3 | ± 361.9 | 86.5 | 5.8 | 2,260.0 | 1 | 43 |
Asian | 6 | 187.4 | ± 361.1 | 55.5 | 5.0 | 922.4 | - | 6 |
Native Hawaiian or other Pacific islander | 1 | 333.2 | - | 333.2 | 333.2 | 333.2 | - | 1 |
Other | 4 | 66.9 | ± 51.3 | 64.4 | 18.6 | 120.3 | - | 4 |
Multiple | 5 | 37.9 | ± 38.5 | 37.1 | 5.0 | 100.2 | - | 5 |
Race of the participant vs N-terminal pro B-type natriuretic peptide
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 297 | 215.4 | ± 438.3 | 84.4 | 5.0 | 4,369.0 | 2 | 299 |
White | 240 | 225.9 | ± 452.4 | 84.3 | 5.0 | 4,369.0 | 1 | 241 |
American Indian or Alaskan Native | 2 | 55.3 | ± 6.7 | 55.3 | 50.6 | 60.1 | - | 2 |
Black or African American | 40 | 199.2 | ± 432.0 | 99.7 | 7.6 | 2,760.0 | 1 | 41 |
Asian | 6 | 140.6 | ± 281.1 | 25.5 | 10.5 | 713.7 | - | 6 |
Native Hawaiian or other Pacific islander | 1 | 232.2 | - | 232.2 | 232.2 | 232.2 | - | 1 |
Other | 3 | 93.6 | ± 57.3 | 102.7 | 32.3 | 145.8 | - | 3 |
Multiple | 5 | 67.1 | ± 43.4 | 89.9 | 16.8 | 104.4 | - | 5 |